Disseminated cat-scratch disease during abatacept therapy for rheumatoid arthritis in an older patient: A case report and review of the literature
- PMID: 40379021
- DOI: 10.1016/j.jiac.2025.102732
Disseminated cat-scratch disease during abatacept therapy for rheumatoid arthritis in an older patient: A case report and review of the literature
Abstract
Cat-scratch disease (CSD) is a zoonotic infection primarily caused by Bartonella henselae following cat scratches. It typically presents with localized skin symptoms and self-limiting lymphadenopathy; however, in some cases, it can progress to disseminated lesions, leading to severe complications. We report a case of CSD with multiorgan involvement in a 79-year-old woman undergoing abatacept treatment for rheumatoid arthritis. She presented with persistent fever and painful right axillary lymphadenopathy, accompanied by induration on the right hand caused by a cat scratch. Imaging studies revealed multiple enlarged lymph nodes as well as hepatosplenic and cervical spine lesions. Initially, the patient was clinically diagnosed with CSD and initiated on azithromycin monotherapy; however, her symptoms persisted. A right axillary lymph node biopsy was performed to re-evaluate the diagnosis. Histopathological analysis showed numerous necrotizing granulomas with multinucleated giant cells, and a polymerase chain reaction assay confirmed the presence of B. henselae in the lymph node, establishing the diagnosis of CSD with multiorgan involvement. Treatment was adjusted to an azithromycin and rifampicin combination, resulting in a gradual improvement in symptoms. CSD may present as a fever of unknown origin with extranodal involvement affecting organs, such as the liver, spleen, bones, and central nervous system, or causing infective endocarditis, complicating the diagnosis. In immunosuppressed patients receiving biological agents for rheumatic diseases, a comprehensive evaluation is crucial. This should include a detailed medical history, physical examination, and comprehensive histological and microbiological assessments to differentiate CSD from conditions such as tuberculosis and malignant lymphoma.
Keywords: Bartonella henselae; Biological agents; Cat-scratch disease; Rheumatoid arthritis.
Copyright © 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Similar articles
-
CASE REPORT OF CAT SCRATCH DISEASE (BARTONELLA).Georgian Med News. 2025 Feb;(359):15-17. Georgian Med News. 2025. PMID: 40305794
-
Disseminated cat-scratch disease: case report and review of the literature.Paediatr Int Child Health. 2016 Aug;36(3):232-4. doi: 10.1179/2046905515Y.0000000005. Paediatr Int Child Health. 2016. PMID: 25940800 Review.
-
Cat scratch disease during etanercept therapy in a rheumatoid arthritis patient.Reumatol Clin (Engl Ed). 2018 Sep-Oct;14(5):303-306. doi: 10.1016/j.reuma.2017.01.008. Epub 2017 Feb 28. Reumatol Clin (Engl Ed). 2018. PMID: 28256443 English, Spanish.
-
Cat-scratch fever and lymphadenopathy in a rheumatoid arthritis patient on tocilizumab.J Clin Rheumatol. 2015 Jan;21(1):40. doi: 10.1097/RHU.0000000000000203. J Clin Rheumatol. 2015. PMID: 25539435 Review. No abstract available.
-
A case report of diagnosis of cat-scratch disease using metagenomic next-generation sequencing.Front Cell Infect Microbiol. 2024 Jan 15;13:1322651. doi: 10.3389/fcimb.2023.1322651. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38287977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous